WASHINGTON, March 07, 2024 (GLOBE NEWSWIRE) -- EB5 Capital announced today that investors in its The Highline (JF13) project have begun receiving I-829 approvals from the United States Citizenship and Immigration Services (USCIS). USCIS issues approval of the removal of conditions of residency for EB-5 investors who have completed their conditional residency period and have demonstrated that their investment has resulted in the creation of at least 10 full-time jobs. I-829 approvals permit continued residence in the U.S. without conditions of restrictions and opens a path to U.S. citizenship for EB-5 investors.
This first I-829 approval in The Highline (JF13) project was granted two and a half years after the petition was filed with the USCIS. “The I-829 petition is the final step in the immigration process for EB-5 investors and we are pleased that the first I-829 was adjudicated within a reasonable period of time,” said Molly FitzGerald, EB5 Capital’s Director of Investor Communications and Engagement.
The Highline (JF13) is a mixed-use 317-unit Class A apartment building with ground-floor retail space in Washington, DC’s NoMa neighborhood. EB5 Capital has raised more than $175 million across six EB-5 projects in NoMa, which has the highest concentration of EB-5 financed projects in the city and has resulted in the creation of over 4,000 jobs. The Highline (JF13), EB5 Capital’s third development in NoMa, opened in 2019 and was successfully refinanced a few months later.
The development of The Highline (JF13) resulted in the creation of over 600 jobs for the local economy in Washington, DC and is one of EB5 Capital’s 20 projects in the nation’s capital. EB5 Capital remains dedicated to identifying and executing projects that contribute meaningfully to local communities and economies across the United States.
About EB5 Capital
EB5 Capital provides qualified foreign investors with opportunities to invest in job-creating commercial real estate projects under the United States Immigrant Investor Program (EB-5 Visa Program). Headquartered in Washington, DC, EB5 Capital’s distinguished track record and leadership in the industry has attracted investors from over 75 countries. As one of the oldest and most active Regional Center operators in the country, the firm has raised over $1 billion of foreign capital across more than 35 EB-5 projects. 100% of our investors’ funds are protected by the Federal Deposit Insurance Corporation (FDIC) insurance prior to their deployment into our projects. Please visit www.eb5capital.com for more information.
Contact:
Katherine Willis
Director, Marketing & Communications
media@eb5capital.com
-
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cVANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a di2024-06-17
-
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market InfrastructureTechnology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products2024-06-17
-
Adalvo 的 Liraglutide 預充式注射筆成為歐盟首款獲得批准的仿製藥馬爾他聖瓜安, June 17, 2024 (GLOBE NEWSWIRE) -- Adalvo 宣布 Liraglutide 預充式注射筆成功取得 DCP 批准,成為歐盟首款獲得批准的仿製藥。 根據 IQVIA 的報2024-06-17
-
促进生育,助力三胎——“三胎免费生”联合公益行动正式启动为积极响应国家号召实施三胎生育政策,扩大妇幼服务健康供给,在云南省优生优育妇幼保健协会指导下,昆明广播电视台联合昆明安琪儿妇产医院,于6月13日在昆明广播2024-06-17
-
学党史传承红色精神 守党纪筑牢自律防线——平安养老险湖南分公司党支部开展主题党日活动七一前夕,平安养老险湖南分公司党支部全体成员走进“千年学府、百年师范”——湖南第一师范,开展了一次学史明理、学史增信、学史崇德、学史力行的主题党日活动。重2024-06-17